Evoke Pharma, Inc. Stock price
Is Evoke Pharma, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Evoke Pharma, Inc. Stock Analysis
Analyst Opinions
6 Analysts have issued a Evoke Pharma, Inc. forecast:
Analyst Opinions
6 Analysts have issued a Evoke Pharma, Inc. forecast:
Don't miss a Thing! We will send you all news about Evoke Pharma, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Evoke Pharma, Inc. Stock News
Company Profile
Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.
| Head office | United States |
| CEO | Mr. D'Onofrio |
| Employees | 3 |
| Founded | 2007 |
| Website | evokepharma.com |


